BioSpace News Archive

LUNGevity Foundation, the nation’s premier lung cancer-focused nonprofit organization, announced today that it is launching Breathe Easier: An Emergency Response Fund to help financially support life challenges for lung cancer patients and their families during the time of the COVID-19 public health emergency.

Competition received novel submissions from data analytics, mathematics and statistics students and professionals worldwide

An unprecedented public health campaign aimed at slowing the spread of coronavirus is having a near-universal effect on public behavior, the third week of a Massachusetts tracking poll finds.

The OptoSeq 3' mRNA Library Kit allows users of Berkeley Lights’ platform to efficiently prepare cells of interest for genomic sequencing opening the door to directly link phenotype to genotype using a single system.

Phio Pharmaceuticals Corp. announced that it has entered into definitive agreements with several institutional investors for the purchase and sale of 1,713,064 shares of Phio’s common stock, at a purchase price of $2.335 per share, for gross proceeds of approximately $4.0 million in a registered direct offering priced at-the-market under Nasdaq rules.

Joining the global fight against the COVID-19 virus, GreyScan has officially launched development of the TVD-1, the world’s first fieldable trace virus detector.

Retractable Technologies, Inc. reports the following information relating to the year ended December 31, 2019.

The Maryland-based urgent care company can also test for COVID-19 after a full medical evaluation

New IgM and IgG antibody assays will help indicate whether a person potentially developed immunity against the coronavirus (SARS-CoV-2)

Hoffmann-La Roche Limited is pleased to announce the launch of the COVID-19 Open Innovation Challenge to encourage Canadians to help develop solutions to the challenges we face from the COVID-19 pandemic.